by Marie O'Brien | Jul 28, 2022 | News
We are very excited to announce that ReNewVax Ltd is now a proud member of Bionow. Bionow supports business growth, competitiveness and innovation within the biomedical and life science sectors across Northern England (https://www.bionow.co.uk/). Bionow currently have...
by Marie O'Brien | Jul 17, 2022 | News
ReNewVax will attend BIO-Europe in Leipzig, Germany on October 24th-26th, 2022. The event is expected to gather over 4,000+ global biopharma executives. We will be particularly focussed on the themes Respiratory and Infectious diseases, Immune profiling, Vaccine...
by Marie O'Brien | Jun 30, 2022 | News
ReNewVax was selected as one of the start-ups companies that will exhibit at the World Vaccine Congress Europe in Barcelona, on 11-14th October 2022. We look forward to presenting our lead vaccine programme and would be happy to talk with partners or investors who are...
by Marie O'Brien | Jun 17, 2022 | News
ReNewVax attended the 12th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD), which took place in Toronto, Canada on 19-23 June 2022. The event was attended by over 1,000 delegates from around the globe, and included researchers, clinicians,...
